Positive results from phase I clinical trial of SMT D002 for the treatment of Seborrhoea (22 Apr 2008) SMT D002 suppresses sebum levels by 90% in repeat-dosetrial - Results from trial support a previous positive Phase I single-dose study conducted...
Summit Corporation plc announced a positive outcome from its repeat-dose Phase I clinical trial of SMT D002, its candidate for the treatment of seborrhoea...
MorphoSys Discloses GM-CSF as Target of MOR103 Program (18 Jan 2008) Exclusive License Obtained to Key Patent from the University of Melbourne -controlled, single-ascending dosetrial and will be conducted in healthy... submitted a clinical trial application (CTA) in the Netherlands to initiate a phase 1 clinical trial using the HuCAL-derived antibody MOR103 for the treatment...
LANI completes Phase I in Japan and to commence Phase I in UK (27 Apr 2007) to 40 healthy volunteers using a single dose, and will trial up to four separate, single dose levels. The study is being funded as part of a US$5.6 million grant... that it has completed a Phase I clinical trial in Japan on CS8958 and expects...
Millennium Announces Promising Findings from Novel Antibody-Chemotherapeutic (22 Feb 2005) ascending dosetrial indicated the molecule was well tolerated and produced...
Millennium Pharmaceuticals, Inc. announced final results from a phase I clinical trial of MLN2704 in patients with advanced hormone-refractory prostate cancer...
Top
